Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of lactobacillus rhamnosus strain LRa05 in preparation of immunity enhancing product and/or eczema relieving product

A technology of Lactobacillus rhamnosus and enhancing immunity, which is applied in the field of microorganisms and can solve the problem of small selection space

Pending Publication Date: 2022-07-22
JIANGSU WECARE BIOTECHNOLOGY CO LTD
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Among them, Lactobacillus rhamnosus (Lactobacillus rhamnosus) is a kind of probiotics. This type of bacteria has been reported to have beneficial effects in many aspects such as improving immunity, relieving constipation, and regulating intestinal tract. Lactobacillus rhamnosus cannot yet meet the multiple selection needs of industrial production, markets and consumers, and there is less room for selection, especially in terms of enhancing immunity and relieving eczema. The Lactobacillus rhamnosus strains provided by the prior art in the art Less, so more beneficial new strains of Lactobacillus rhamnosus still need to be developed in this field

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of lactobacillus rhamnosus strain LRa05 in preparation of immunity enhancing product and/or eczema relieving product
  • Application of lactobacillus rhamnosus strain LRa05 in preparation of immunity enhancing product and/or eczema relieving product
  • Application of lactobacillus rhamnosus strain LRa05 in preparation of immunity enhancing product and/or eczema relieving product

Examples

Experimental program
Comparison scheme
Effect test

experiment example 2

[0061] The control strain Lactobacillus rhamnosus LGG strain used in Experimental Example 2 was purchased from the Guangdong Microorganism Culture Collection;

[0062] Escherichia coli, Staphylococcus aureus, and Salmonella used in Experimental Examples 6-7 were purchased from Guangdong Microorganism Culture Collection Center.

[0063] The mice used in Experimental Examples 8-9 were purchased from the Animal Center of Huazhong Agricultural University.

[0064] The first group of examples, the use of the product of the strain LRa05 of the present invention

[0065] The examples in this group provide the use of Lactobaccillus rhamnosus strain LRa05 with a deposit number of CGMCC No. 24377 in the preparation of immunity-enhancing products and / or eczema-relieving products.

[0066] Any use, preparation, production, sale, offering for sale, cultivation, propagation, fermentation of Lactobaccillus rhamnosus strain LRa05 with the deposit number of CGMCC No. 24377 and its use in the ...

experiment example 1

[0102] Experimental example 1. Isolation, screening and identification of Lactobacillus rhamnosus

[0103] (1) Isolation and screening of strains

[0104] Collect fecal samples from healthy humans, take 1 g to 9 mL of sterile saline, fully shake and disperse the samples, take 100 μL of samples for gradient dilution, select an appropriate gradient and evenly spread them on MRS agar plates, place them under anaerobic conditions, and incubate at 37 ° C for 36 After ~48h, a single suspected single colony was selected, gram staining was performed, and the morphological characteristics of the colony were observed by microscopy, and the strains suspected of Lactobacillus were initially screened. The strain was repeatedly streaked and purified on MRS solid medium to obtain a purified strain of Lactobacillus, and then the purified strain was stored in a -80°C glycerol tube.

[0105] MRS medium formula (g / L): peptone 10, beef extract 5, yeast powder 5, glucose 20, anhydrous sodium acet...

experiment example 3

[0120] Experimental Example 3. Comparison Experiment of Lactobacillus rhamnosus Fermentation Tank Enlargement

[0121] Seed culture: insert Lactobacillus rhamnosus into 10 mL of seed medium, and stand at 37°C for 6-8 hours to be the first-class seeds. In 200mL seed medium, 37 ℃ static culture for 5-6h is the secondary seed.

[0122] Fermentation tank culture: the volume of the fermenter is 15L, 10L of fermentation medium is put into it, sterilized at 115°C for 20min, and all the secondary seeds obtained from the culture are inoculated into the fermenter with an inoculation amount of 2% (v / v). Fermentation was started under the conditions of 35°C, stirring speed of 100 rpm, and initial pH of 6.5. During the fermentation, 23% sodium carbonate was used to maintain the pH at 5.8, and nitrogen was introduced to maintain the tank pressure at 0.03 MPa for 10 hours. The number of viable bacteria in the obtained fermentation broth is shown in Table 2 below.

[0123] The formula of th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of a lactobacillus rhamnosus strain LRa05 in preparation of products for enhancing immunity and / or products for relieving eczema, and relates to the technical field of microorganisms. The invention provides a lactobacillus rhamnosus strain LRa05 and an application of the lactobacillus rhamnosus strain LRa05 in the aspect of preparing a product for enhancing immunity and / or a product for relieving eczema. The preservation number of the lactobacillus rhamnosus strain LRa05 is CGMCC (China General Microbiological Culture Collection Center) No.24377, and the lactobacillus rhamnosus strain LRa05 is a lactobacillus rhamnosus strain LRa05. The strain LRa05 has relatively strong bacteriostatic ability and good anti-inflammatory and immunoregulation functions, and has a regulation effect on mouse splenic lymphocyte transformation value, cell inflammatory factors and intestinal short-chain fatty acid level; the immune cell activity can be promoted, the inflammation response is reduced, and the symptoms of eczema patients are remarkably improved.

Description

technical field [0001] The invention relates to the technical field of microorganisms, in particular to the use of Lactobacillus rhamnosus strain LRa05 in the preparation of immunity-enhancing products and / or eczema-relieving products. Background technique [0002] The intestinal tract is the most densely populated part of the human body and is the largest immune organ in the human body. There are a large number of immune cells on the intestinal mucosa. Immunity is the body's defense mechanism that can deal with mutant cells in the body and cells infected by foreign viruses, bacteria, etc. Under normal circumstances, the immune system will recognize and destroy the invading foreign body, and the mutant cells will be suppressed and eliminated. Challenges such as environment, infection, aging, lifestyle, surgery, and malnutrition can lead to dysbiosis of gut flora and low immunity. Intestinal flora imbalance will increase the growth of pathogenic bacteria in the intestinal t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N1/20A61K35/747A61P37/04A61P17/00A61P29/00A61P37/08A23C9/123A23L33/135C12R1/225
CPCC12N1/20A61K35/747A61P37/04A61P17/00A61P29/00A61P37/08A23C9/1234A23L33/135A23V2002/00A23V2400/175A23V2200/3204A23V2200/324A23V2200/318A23V2200/304
Inventor 方曙光左慧玉朱明明陈明阳宋沙沙
Owner JIANGSU WECARE BIOTECHNOLOGY CO LTD